Therapeutics
Search By Attributes
Search Results
| Name | Synonyms | FDA Status | Company | Target Type | Therapy Type | Condition | Approved For |
|---|---|---|---|---|---|---|---|
| Bapineuzumab | AAB-001 | Discontinued | Janssen, Pfizer | Amyloid-Related | Immunotherapy (passive) | Alzheimer's Disease | |
| Gammagard® | Intravenous Immunoglobulin, IVIg |
Discontinued | Baxter Healthcare | Amyloid-Related, Inflammation | Immunotherapy (passive) | Alzheimer's Disease | Immunodeficiency conditions |
| Ponezumab | PF-04360365 | Discontinued, 2 | Pfizer | Amyloid-Related | Immunotherapy (passive) | Alzheimer's Disease, Cerebral Amyloid Angiopathy | None |
| RG7345 | RO6926496 | Discontinued | Roche | Tau | Immunotherapy (passive) | Alzheimer's Disease |